Suchergebnisse - "Vincent, C"

PubPharm (49)

1

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sangro, B. | Chan, S. | Kelley, R. | +123

2

The Effects of a Blended Care Intervention in Partners of Patients With Acquired Brain Injury - Results of the CARE4Carer Randomized Controlled Trial

enthalten in: Archives of physical medicine and rehabilitation | 2024

von Welten, J. | Cox, V. | van Eijk, R. | +3

3

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy : results from the randomised phase 3 'LIVE-AIR' trial

enthalten in: Thorax | 2023

von Temesgen, Z. | Kelley, C. | Cerasoli, F. | +110

4

Comparison of lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis

enthalten in: Gut | 2023

von Boxhoorn, L. | Verdonk, R. | Besselink, M. | +38

CommentIn: Gut. 2023 May;72(5):1025-1026. - PMID 35777962

5

Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer

enthalten in: British journal of cancer | 2022

von Doherty, M. | Tam, V. | McNamara, M. | +11

6

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4) : a randomised, double-blind, double placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Wolfe, C. | Tomashek, K. | Patterson, T. | +162

CommentIn: Ann Intern Med. 2022 Oct;175(10):JC115. - PMID 36191322

7

Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis : A Secondary Analysis of a Randomized Clinical Trial

enthalten in: JAMA network open | 2022

von Manyazewal, T. | Woldeamanuel, Y. | Fekadu, A. | +2

8

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation : an exploratory, randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Ely, E. | Ramanan, A. | Kartman, C. | +25

CommentIn: Lancet Respir Med. 2022 Apr;10(4):314-315. - PMID 35123659

9

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR) : a phase 3, randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Temesgen, Z. | Burger, C. | Baker, J. | +113

CommentIn: Lancet Respir Med. 2022 Mar;10(3):223-224. - PMID 34863335

10

Cognitively Based Compassion Training for HIV Immune Nonresponders-An Attention-Placebo Randomized Controlled Trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Titanji, B. | Tejani, M. | Farber, E. | +9

1
2
3
4
5
Nächster »
[5]